No abstract available
MeSH terms
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal, Humanized
-
Antiviral Agents / administration & dosage*
-
Antiviral Agents / economics
-
Child
-
Child, Preschool
-
Cost-Benefit Analysis
-
Cross-Sectional Studies
-
Evidence-Based Medicine*
-
Health Care Costs / statistics & numerical data
-
Humans
-
Infant
-
Infant, Newborn
-
Infant, Premature, Diseases / economics
-
Infant, Premature, Diseases / immunology
-
Infant, Premature, Diseases / prevention & control*
-
Palivizumab
-
Population Surveillance
-
Practice Guidelines as Topic
-
Respiratory Syncytial Virus Infections / diagnosis
-
Respiratory Syncytial Virus Infections / economics
-
Respiratory Syncytial Virus Infections / immunology*
-
Respiratory Syncytial Virus Infections / prevention & control*
-
Respiratory Syncytial Viruses / drug effects*
-
Respiratory Syncytial Viruses / immunology*
-
Risk Factors
-
United States
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antiviral Agents
-
Palivizumab